Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Finance & Markets

Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?

Key PointsThe purchase involved 23,900 shares at $20.85 per share, representing an investment of ~$498,000.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Tuesday 18 August →